Stocks · Health care · Pharmaceutical Preparations

ALX ONCOLOGY HOLDINGS INC

ALXO Clue Score32
United States Fiscal year ends December CIK 0001810182 Results filed 6 Aug 2026

What the insiders did Net buying

By person

6 insiders · 8 transactions
0.7×

Jason Lettmann holds only 0.7 times base salary in stock. $568.15K of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Lettmann last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Corey S Goodman
Director
$5.00M (1)
—
+$5.00M
8,453,038
$16.31M
+60.5%
Jason Lettmann
Chief Executive Officer
—
$31.02K (2)
−$31.02K
294,379
$568.15K
+62.3%
Shelly Wong
SVP, Finance and CAO
—
$11.57K (5)
−$11.57K
87,828
$169.51K
−12.7%
Jaume Pons
President & CSO
—
—
—
579,388
$1.12M
−2.0%
Harish Shantharam
Chief Financial Officer
—
—
—
75,000
$144.75K
—
Rekha Hemrajani
Director
—
—
—
33,000
$63.69K
+1,000%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 53,444,020 to 138,276,997 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.